The WACC of Allergy Therapeutics PLC (AGY.L) is 7.3%.
Range | Selected | |
Cost of equity | 6.00% - 8.30% | 7.15% |
Tax rate | 11.10% - 15.20% | 13.15% |
Cost of debt | 7.00% - 13.10% | 10.05% |
WACC | 6.0% - 8.6% | 7.3% |
Category | Low | High |
Long-term bond rate | 4.0% | 4.5% |
Equity market risk premium | 6.0% | 7.0% |
Adjusted beta | 0.34 | 0.47 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 6.00% | 8.30% |
Tax rate | 11.10% | 15.20% |
Debt/Equity ratio | 0.13 | 0.13 |
Cost of debt | 7.00% | 13.10% |
After-tax WACC | 6.0% | 8.6% |
Selected WACC | 7.3% | |